Applications Published 15 November 2000

Published: 25-Jun-2001

aThe following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).


aThe following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT).

  • Microparticle inhaltion formulations
    RTP Pharma 1051154*

  • Nasal solutions
    Novartis Consumer Health 1051155*

  • Pharmaceutical compsns
    Glaxo Group 1051156*

  • Controlled release delivery of peptide or protein
    Scios 1051157*

  • Pharmaceutical compsns in form of polymeric microparticles obtained by extrusion and spheronizartion
    Eurand International 1051158*

  • Solid pharmaceutical comnpsns containing miltefosine for oral admionistration in the treatment of leishmaniasis
    ASTA Medica 1051159*

  • Pharmaceutical compsns in form of nanoparticles comprising lipidic substances and aphiphilic substances and related preparation process
    Eurand International 1051160*

  • Method for treating Alzheimer's disease
    Warner-Lambert 1051161*

  • Method and kits for treating vulvovaginal candidiasis with micronazole nitrate
    McNeil-PPC 1051162*

  • Methods and compsns for aiding in smoking cessation and for treating pain and other disorders using optically pure (-)-bupropion
    Sepracor 1051163*

  • Pharmacological uses of pure (+)-bupropion
    Sepracor 1051164*

  • Mitochondira protecting agents for treating mitochondria associated diseases
    Mitokor 1061165*

  • Pharmceutical uses of optically pure (+)-bupropion
    Sepracor 1061166*

  • Pharmaceutical uses of optically pure (+)-bupropion
    Sepracor 1061167*

  • Compsns, apparatus and methods for facilitating surgical procedures
    Duke University 1061168*

  • Compounds, compsns and methods for treating or preventing pnemovirus infection and associated diseases
    Viropharma 1061169*

  • Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neuronal regeneration
    Bayer 1051170*

  • Method for treating COPD
    SmithKline Beecham 1051172*

  • Derivatives of 1,3,4-oxadiazolone
    Bristol-Myers Squibb 1051173*

  • Gastroprotected omeprazole microgranules, method for obtaining same and pharmaceutical preparations
    Ethylpharmn 1051174*

  • Use of bicozamycin for the manufacture of a medicament for treating infections with enterohemorrhagic E coli
    Fujisawa Pharmaceuticals 10511175*

  • Substituted oxoazaheterocyclyl factor XA inhibitors
    Aventis Pharmaceuticals 1051176*

  • Steroid 3-O-sulphamate derivatives as inhibitors of oestrone sulphatase
    Sterix 1051177*

  • Steroid 3-O-sulphamate derivatives as inhibitors of oestrone sulphatase
    Sterix 1051178*

  • Anti-oestrogen plus progestin containing oral contraceptives
    American Home Products 1051179*

  • Phospholipids having antimicrobial activity with or without the presence of antimicrobials
    Statens Seruminstitut 1051180*

  • Water soluble prodrugs of secondary and tertiary amine containing drugs and methods of making thereof
    The University of Kansas 1051181*

  • Methods of decreasing or preventing pain using spicamycin or derivatives thereof
    The General Hospital Corporation 1051182*

  • Peritoneal dialysis solution containing modified icodextrins
    Baxter International 1051183*

  • Pharmaceutical compsn comprising vanadium and/or salts thereof and its use to treat burns
    Vlaams Interuniversitair Instituut voor Biotechnologie 1051184*

  • Anti-fungal compsns with prolonged activity
    Farmo-Nat 1051185*

  • Synergistic mixtures of garlic and lycopene for preventing LDL Oxidation
    Lycored Natural Products Industries 1051186*

  • Treatment of follicular lymphomas using inhibitors of the lymphotoxin (LT) pathway
    Biogen 1051187*

  • Mucosal delivery system comprising lipophilic thrombin inhibitors
    West Pharmaceutical Services Drug Delivery & Clinical Research Centre 1051188*

  • Vaccine formulations
    Boehringer Ingelheim Pharmaceutical 1051189*

  • Vaccine compsns for mucosal administration comprising chitosan
    West Pharmaceutical Services Drug Delivery & Clinical Research Centre 1051190*

  • CD154 blockade therapy for pancreatic islet tissue transplantation
    Biogen; University of Miami 1051191*

  • Methods for the prevention and treatment of fibrosis and sclerosis
    Link Trinagle 1051192*

  • Anhydrous topical skin preparations
    Johnson & Johnson Consumer Companies 1051193*

  • Process for making absorbable microparticles
    Kinerton 1051194*

  • Identification of agents that protect against inflammatory injury to neurons
    Baylor College of Medicine 1051195*

  • Compsns for detecting and surgically removing lymphoid tissue involved in tumour progression
    Biocrystal 1051196*

  • Process for the production of monoglyceride based on the glycerolysis of methyl ester
    Global Palm Products 1051386*

  • Anticancer platinum (IV) complexes for oral administration
    Korea Institute of Technology 1051387*

  • Method for producing optically active amino alcohols
    Bayer 1051388*

  • Method for producing oxalkylated amines or alcohols
    BASF 1051389*

  • Compounds for molecular separations
    Molecular Dynamics 1051390*

  • Adamatanecarboximidamide derivatives and their use as NMDA antagonists
    Vernalis Research 1051392*

  • New derivatives of sulphonic, phosphonic and phosphinic aminoalkane acids, their production and their use as medicaments
    Lipha 1051393*

  • Potassium channel inhibitors
    Icagen 1951394*

  • Hydroxamic acid and carboxylic acid derivatives
    Darwin Discovery 1051395*

  • Competitive inhibitors of glycoxalase I and method of generating such competitive inhibitors inside tumour cells
    University of Maryland at Baltimore County 1051396*

  • Method for preparing an N-(aliphatic or aromatic)carbonyl]-2-aminoacetamide compound and a cyclysed compound
    Aventis Pharmaceutical Products 1051397*

  • Phenylalanine derivatives useful as pharmaceutical agents
    Celltech Therapeutics 1051399*

  • Cyclic alkyleneureas containing monomers and polymers and latices therefrom
    Rhodia 1051400*

  • Process for the production of formylimidazoles
    Lonza 1051401*

  • Method for producing S-alkyl(aryl)-substituted imidazol derivatives
    Aventis Pharma Deutschland 1051402*

  • Novel alkanoic acids and their uses in medicine process for their preparation and pharmaceutical compsns containing them
    Dr Reddy's Research Foundation 1051403*

  • Substituted phenyluracils with herbicidal effect
    Bayer 1051404*

  • Novel dihydrohexanoic acid derivatives
    Pfizer Products 1051405*

  • Super-absorbing polymeric networks
    Donlar 1051406*

  • Fluorochemical benzotriazoles
    Minnesota Mining and Manufacturing 1051408*

  • benzo[B[pyran derivatives useful as external agents for the skin
    Pola Chemical Industries 1051410*

  • Methods for separating a tocol from a tocol-containing mixture
    Eastman Chemical 1051411*

  • Methods for separating a tocotrienol from a tocol-containing mixture and compsns thereof
    Eastman Chemical 1051412*

  • Quinoline derivatives as antibacterials
    SmithKline Beecham 1051413*

  • Benzamide derivatives as vasopressin antagonists
    Fujisawa Pharmaceutical 1051415*

  • 1m4-diazacycloheptane derivatives for the treatment of neurological disorders
    AstraZeneca 1051416*

  • Process for the preparation of substituted 8-azabicyclo[3.2.1]octanes
    Zeneca 1051418*

  • Deprotection and recrystallisation processes
    Bristol-Myers Squibb 1051419*

  • New cytotoxic tris9oxazole)-containing macrolides
    Instituto Biomar 1051420*

  • Process for the synthesis of polyol fatty acid polysters
    Procter & Gamble 1051423*

  • Novel synthesis for oligonucleotide synthesis
    Hybridon 1051424*

  • 67 secreted human proteins
    Human Genome Sciences 1051426*

  • Spoil protein and nucleic acid molecules and uses therefor
    Millennium Pharmaceuticals 1051427*

  • Human cystatin F
    Human Genome Sciences 1051428*

  • LDL related protein and uses thereof
    Millennium Pharmaceuticals 1051429*

  • Array fabrication methods
    Affymetrix 1051430*

  • Thrombin inhibitors
    BASF 1051431*

  • Method of reducing immunogenicity of proteins
    Biovation 1051432*

  • Antimicrobial peptides
    Stichting voior Technische Wetenshcappen 1051433*

  • G protein coupled receptor
    AstraZeneca 1051434*

  • Novel stroid-activated nuclear receptors and uses therefor
    The Salk Institute 1051479*

  • Enzyme activated supports for enantiomeric separations
    Pharm-Eco Laboratories 1051480*

  • Secreted proteins and polynucelotides encoding them
    Genetics Institute 1051481*

  • Cytotoxic heteromeric protein combinatorial libraries
    The Ontario Cancer Institute 1051482*

  • A method of isolating a peptide which immunologically mimics microbial carbohydrates including group B streptococcal carbohydrates and the use thereof
    Pincus, Seth 1051483*

  • Gene regulator fusion proteins and methods of using the same for determining resistance of a protein to a drug targeted thereagainst
    Sepracor 1051484*

  • Trek-1 kike two-pore potassium channel
    SmithKline Beecham 1051485*

  • GTPase derived from human lymph nodes that effects the morphology and cytoskeleton organisation of endothelial cells
    AstraZeneca 1051486*

  • Human growth factor monologues
    Incyte Pharmaceuticals 1051488*

  • Compounds forthe therapy and diagnosis of lung cancer and methods for use
    Corixa Corp 1051489*

  • Modulation of cell proliferation, methods and reagents
    Cold Spring Harbour Labs 1051490*

  • Method for producing antibody fragments
    Unilever 1051493*

  • Methods and reagents for decreasing allergic reactions
    The University of Arkansas; The Mount Sinai School of Medicine, of the City University of New York 1051494*

  • Recombinant mistletoe lectines
    Biosyn Anznemittel 1051495*

  • Human protein kinase molecules
    Incyte Pharmaceuticals 1051497*

  • Tyrosylprotein sulphotransferase polypeptides and polynucleotides
    The Board of Regents of the University of Oklahoma 1051499*

  • Nucelic acid molecule encoding a cephalosporin acetylesterase
    Biochemie Gesellschaft 1051501*

  • Process of extracting taxol from Taxus cuspidata
    Han, Man Woo; Hong, Nam Doo; Yoo, Jae Kuk 1051505*

  • Process for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugates vaccines
    North American Vaccines 1051506*

  • Antigen-specific cells, methods of generating these cells and uses thereof
    Genzyme 1051507*

  • Pancreatic eukaryotic translation initiation factor-2 alpha kinase
    Eli Lilly 1051508*

  • A rapid method for the assessment of the inhibition and kill of anaerobic bacteria by toxic compounds
    Nalco Chemical 1051510*
    See more

    • You may also like

    Medical Devices

    Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

    Read more
    A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies

    Trending Articles

    1. Continuous innovation: redefining the future of pharmaceutical manufacturing In an industry in which reliability is paramount and change can be slow, GEA has consistently proven that innovation and stability go hand in hand. Almost two decades ago, GEA introduced the first ConsiGma® continuous manufacturing (CM) system to the pharmaceutical market — a pioneering move that helped to reshape how oral solid dosage (OSD) forms are developed and produced
    2. Abselion launches AAVX and AAV9 Total Capsid Quantification Kits Ready-to-use solution for Amperia benchtop platform supports rapid, reliable quantification across a range of serotypes
    3. diaago and Peak Analysis & Automation partner to bring practical automation solutions to research laboratories Using diaago's customer-first approach with PAA’s decades of expertise in laboratory robotics, the collaboration promises to deliver solutions to streamline workflows, boost throughput and reduce bottlenecks
    4. Suncombe and Kindeva collaborate to deliver low-carbon inhalers to the NHS The partnership will develop next-generation pressurised metered-dose inhalers with low Global Warming Potential propellants, helping the NHS move closer to its Net Zero target
    5. Douglas Pharmaceuticals sets new benchmark for capsule quality with CI Precision Partnership delivers compliance confidence, efficiency gains and reduced waste

    Upcoming event

    Enhancing probiotic stability through smarter formulation and packaging strategies

    18 September 2025 | Virtual     See all

    You may also like

    Medical Devices

    Syensqo introduces medical-grade Amodel PPA for single-use, high-temperature medical devices

    A new medical-grade Amodel PPA delivers high heat resistance, electrically insulative properties, and biocompatibility for advanced single-use medical instruments and assemblies
    Manufacturing

    Sapio Sciences introduces world’s first 3rd-generation ELN

    Sapio ELaiN is an AI-powered lab notebook designed to act as a scientific collaborator
    Manufacturing

    Signal Group launches MCERTS approved VOC emissions monitor

    New SOLAR CEMNEX analyser offers advanced compliance and connectivity features
    Research & Development

    Genoskin raises $8.7m in its first funding round to advance its ethical, human-based alternatives to animal testing

    The financing will drive Genoskin’s next phase of growth, with a view to scaling up operations in both the US and France
    You need to be a subscriber to read this article.
    Click here to find out more.
    Packaging

    Cloud labelling and serialisation: the new frontline of traceability in drug delivery

    As drug delivery evolves to accommodate a new wave of data-driven innovation, the need for traceability and compliance throughout the supply chain is paramount. Innovative cloud-based solutions enable pharmaceutical companies to navigate these demands with confidence
    Manufacturing

    Sharp boosts autoinjector and pen assembly line capability with $20m investment in Pennsylvania facility

    The money will boost its autoinjector and pen assembly, labelling and packaging lines across various therapeutic areas at its facility in Macungie, meeting the rising demand for injectables
    Manufacturing

    L.B. Bohle to showcase machines for OSD, food and nutraceuticals at PACK EXPO 2025

    Company to present advanced blending, particle sizing and coating technologies at Las Vegas event
    Subscribe now